Methods . | 5-fold cross-validation . | Jackknife cross-validation . | ||||||
---|---|---|---|---|---|---|---|---|
Sn(%) . | Sp(%) . | Acc(%) . | MCC . | Sn(%) . | Sp(%) . | Acc(%) . | MCC . | |
iRSpot-EL | 75.29 | 88.81 | 82.65 | 0.651 | – | – | – | – |
RF-DYMHC | 73.01 | 86.56 | 80.40 | 0.605 | – | – | – | – |
IDQD-4-mer | 79.52 | 81.82 | 80.77 | 0.616 | – | – | – | – |
IRSpot-PseDNC | 71.75 | 85.84 | 79.33 | 0.583 | – | – | – | – |
IRSpot-TNCPseAAC | 76.56 | 70.99 | 73.52 | 0.474 | – | – | – | – |
IRSpot-ADPM | 77.19 | 90.73 | 84.57 | 0.690 | 76.36 | 90.56 | 84.10 | 0.681 |
IRSpot-PDI | 71.84 | 92.95 | 83.16 | 0.666 | – | – | – | – |
iRSpot-SF | 84.57 | 75.76 | 84.58 | 0.694 | 75.31 | 91.08 | 83.91 | 0.677 |
Methods . | 5-fold cross-validation . | Jackknife cross-validation . | ||||||
---|---|---|---|---|---|---|---|---|
Sn(%) . | Sp(%) . | Acc(%) . | MCC . | Sn(%) . | Sp(%) . | Acc(%) . | MCC . | |
iRSpot-EL | 75.29 | 88.81 | 82.65 | 0.651 | – | – | – | – |
RF-DYMHC | 73.01 | 86.56 | 80.40 | 0.605 | – | – | – | – |
IDQD-4-mer | 79.52 | 81.82 | 80.77 | 0.616 | – | – | – | – |
IRSpot-PseDNC | 71.75 | 85.84 | 79.33 | 0.583 | – | – | – | – |
IRSpot-TNCPseAAC | 76.56 | 70.99 | 73.52 | 0.474 | – | – | – | – |
IRSpot-ADPM | 77.19 | 90.73 | 84.57 | 0.690 | 76.36 | 90.56 | 84.10 | 0.681 |
IRSpot-PDI | 71.84 | 92.95 | 83.16 | 0.666 | – | – | – | – |
iRSpot-SF | 84.57 | 75.76 | 84.58 | 0.694 | 75.31 | 91.08 | 83.91 | 0.677 |
Methods . | 5-fold cross-validation . | Jackknife cross-validation . | ||||||
---|---|---|---|---|---|---|---|---|
Sn(%) . | Sp(%) . | Acc(%) . | MCC . | Sn(%) . | Sp(%) . | Acc(%) . | MCC . | |
iRSpot-EL | 75.29 | 88.81 | 82.65 | 0.651 | – | – | – | – |
RF-DYMHC | 73.01 | 86.56 | 80.40 | 0.605 | – | – | – | – |
IDQD-4-mer | 79.52 | 81.82 | 80.77 | 0.616 | – | – | – | – |
IRSpot-PseDNC | 71.75 | 85.84 | 79.33 | 0.583 | – | – | – | – |
IRSpot-TNCPseAAC | 76.56 | 70.99 | 73.52 | 0.474 | – | – | – | – |
IRSpot-ADPM | 77.19 | 90.73 | 84.57 | 0.690 | 76.36 | 90.56 | 84.10 | 0.681 |
IRSpot-PDI | 71.84 | 92.95 | 83.16 | 0.666 | – | – | – | – |
iRSpot-SF | 84.57 | 75.76 | 84.58 | 0.694 | 75.31 | 91.08 | 83.91 | 0.677 |
Methods . | 5-fold cross-validation . | Jackknife cross-validation . | ||||||
---|---|---|---|---|---|---|---|---|
Sn(%) . | Sp(%) . | Acc(%) . | MCC . | Sn(%) . | Sp(%) . | Acc(%) . | MCC . | |
iRSpot-EL | 75.29 | 88.81 | 82.65 | 0.651 | – | – | – | – |
RF-DYMHC | 73.01 | 86.56 | 80.40 | 0.605 | – | – | – | – |
IDQD-4-mer | 79.52 | 81.82 | 80.77 | 0.616 | – | – | – | – |
IRSpot-PseDNC | 71.75 | 85.84 | 79.33 | 0.583 | – | – | – | – |
IRSpot-TNCPseAAC | 76.56 | 70.99 | 73.52 | 0.474 | – | – | – | – |
IRSpot-ADPM | 77.19 | 90.73 | 84.57 | 0.690 | 76.36 | 90.56 | 84.10 | 0.681 |
IRSpot-PDI | 71.84 | 92.95 | 83.16 | 0.666 | – | – | – | – |
iRSpot-SF | 84.57 | 75.76 | 84.58 | 0.694 | 75.31 | 91.08 | 83.91 | 0.677 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.